膀胱癌免疫治疗后的播散性感染和脊椎骨髓炎
Disseminated Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer.
作者信息
Gill Harpreet S, Dasari Suhas P, Pandit Sarbagya, Ritter Thomas E, Raju Sushma B, Chartier Alexander R, Jha Pinky
机构信息
Department of Internal Medicine, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA.
出版信息
Case Rep Infect Dis. 2020 Dec 28;2020:6676163. doi: 10.1155/2020/6676163. eCollection 2020.
Abstract
The use of BCG in immunotherapy for bladder cancer has been in practice for over 40 years. However, uncommon, serious complications can occur with the therapy. Here, we present a case of vertebral osteomyelitis secondary to dissemination of BCG following immunotherapy, an exceedingly rare presentation of an already rare complication.
摘要
卡介苗用于膀胱癌免疫治疗已有40多年的实践历史。然而，这种治疗可能会出现罕见的严重并发症。在此，我们报告一例免疫治疗后卡介苗播散继发椎体骨髓炎的病例，这是一种极为罕见的并发症的罕见表现。
相似文献
1
Disseminated Infection and Vertebral Osteomyelitis following Immunotherapy for Bladder Cancer.
Case Rep Infect Dis. 2020 Dec 28;2020:6676163. doi: 10.1155/2020/6676163. eCollection 2020.
2
Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases.
Clin Rheumatol. 2019 Jun;38(6):1773-1783. doi: 10.1007/s10067-019-04500-w. Epub 2019 Mar 13.
3
Osteomyelitis and septic arthritis after Mycobacterium Bovis BCG Therapy for Urinary Bladder Cancer.
Clin Imaging. 2020 Dec;68:179-183. doi: 10.1016/j.clinimag.2020.07.016. Epub 2020 Jul 25.
4
Mycobacterium bovis vertebral osteomyelitis and discitis with adjacent mycotic abdominal aortic aneurysm caused by intravesical BCG therapy: a case report in an elderly gentleman.
Age Ageing. 2013 Jan;42(1):129-31. doi: 10.1093/ageing/afs164. Epub 2012 Nov 14.
5
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.
J Clin Microbiol. 1999 Jun;37(6):2106-8. doi: 10.1128/JCM.37.6.2106-2108.1999.
6
Mycobacterium bovis osteomyelitis involving a hip arthroplasty after intravesicular bacille Calmette-Guérin for bladder cancer.
Clin Infect Dis. 1998 Sep;27(3):639-40. doi: 10.1086/514714.
7
Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.
Mayo Clin Proc. 2002 Apr;77(4):393-7. doi: 10.4065/77.4.393.
8
Mycobacterium bovis vertebral osteomyelitis and psoas abscess after intravesical BCG therapy for bladder carcinoma.
Urology. 1992 Jul;40(1):63-6. doi: 10.1016/0090-4295(92)90439-4.
9
BCG spinal osteomyelitis in a patient with bladder cancer without a history of BCG instillation.
BMJ Case Rep. 2018 Jul 30;2018:bcr-2018-224462. doi: 10.1136/bcr-2018-224462.
10
Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.
Clin Med Insights Case Rep. 2016 Aug 16;9:71-3. doi: 10.4137/CCRep.S39904. eCollection 2016.
引用本文的文献
1
Infection of the acromioclavicular joint with Mycobacterium bovis following intravesical instillation of Bacillus Calmette-Guerin: a case-based review.
Infection. 2025 Aug 25. doi: 10.1007/s15010-025-02610-z.
2
Lumbosacral Vertebral Osteomyelitis With Iliopsoas and Epidural Abscess Following Intravesical Bacillus Calmette-Guérin Therapy.
Cureus. 2023 Oct 21;15(10):e47421. doi: 10.7759/cureus.47421. eCollection 2023 Oct.
本文引用的文献
1
BCG-induced discitis and osteomyelitis in a patient with a history of bladder cancer.
JAAPA. 2019 May;32(5):1-4. doi: 10.1097/01.JAA.0000554739.16558.26.
2
Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015.
Emerg Infect Dis. 2019 Mar;25(3):451-456. doi: 10.3201/eid2503.180686.
3
Human Tuberculosis Caused by Mycobacterium bovis in the United States, 2006-2013.
Clin Infect Dis. 2016 Sep 1;63(5):594-601. doi: 10.1093/cid/ciw371. Epub 2016 Jun 13.
4
Mycobacterial Osteomyelitis of the Spine Following Intravesical BCG Therapy for Bladder Cancer.
Cureus. 2016 Mar 26;8(3):e545. doi: 10.7759/cureus.545.
5
Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.
Appl Microbiol Biotechnol. 2015 May;99(9):3741-54. doi: 10.1007/s00253-015-6495-3. Epub 2015 Mar 21.
6
Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.
Medicine (Baltimore). 2014 Oct;93(17):236-254. doi: 10.1097/MD.0000000000000119.
7
Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.
Mayo Clin Proc. 2002 Apr;77(4):393-7. doi: 10.4065/77.4.393.
8
Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.
J Clin Microbiol. 1999 Jun;37(6):2106-8. doi: 10.1128/JCM.37.6.2106-2108.1999.
9
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.
J Urol. 1992 Mar;147(3):596-600. doi: 10.1016/s0022-5347(17)37316-0.
Zotero 插件